SL, W., T, L., M, V., B, R., JS, D., L, H., . . . R, K. (2019). Cancer Neoepitopes for Immunotherapy: Discordance Between Tumor-Infiltrating T Cell Reactivity and Tumor MHC Peptidome Display. Frontiers in immunology, 10, 2766. https://doi.org/10.3389/fimmu.2019.02766
Chicago Style (17th ed.) CitationSL, Wickström, et al. "Cancer Neoepitopes for Immunotherapy: Discordance Between Tumor-Infiltrating T Cell Reactivity and Tumor MHC Peptidome Display." Frontiers in Immunology 10 (2019): 2766. https://doi.org/10.3389/fimmu.2019.02766.
MLA (9th ed.) CitationSL, Wickström, et al. "Cancer Neoepitopes for Immunotherapy: Discordance Between Tumor-Infiltrating T Cell Reactivity and Tumor MHC Peptidome Display." Frontiers in Immunology, vol. 10, 2019, p. 2766, https://doi.org/10.3389/fimmu.2019.02766.